Table: begin end state 1 30 cytoplasmic 31 52 transmembrane 53 96 non-cytoplasmic 97 115 transmembrane 116 122 cytoplasmic 123 145 transmembrane 146 156 non-cytoplasmic 157 181 transmembrane 182 193 cytoplasmic 194 220 transmembrane 221 231 non-cytoplasmic 232 250 transmembrane 251 264 cytoplasmic 265 284 transmembrane 285 285 non-cytoplasmic 286 314 transmembrane 315 325 cytoplasmic 326 351 transmembrane 352 365 non-cytoplasmic
Input: >AO356_17390 MTTHTFKPDMPPPSSSIGVVAWMRANMFSSWLNTLLTLFAFYLIYLIVPPLLQWAILDAN WVGTTRADCTKEGACWVFIQQRFGQFMYGYYPADLRWRVDLTVWAAVLGVAPLFISRFPR KAIYGLSFLVLYPIIAWCLLHGGVFGLDAVATSQWGGLMLTLVIATVGIVGALPLGIVLA LGRRSNMPAIRVVCVTFIEFWRGVPLITVLFMSSVMLPLFLPEGMNFDKLLRALIGVILF QSAYVAEVVRGGLQAIPKGQYEAAAAMGLGYWRSMGLVILPQALKLVIPGIVNTFIALFK DTSLVIIIGLFDLLNSVKQAAADPKWLGMATEGYVFAALVFWIFCFGMSRYSMHLERKLD TGHKR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server